SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

Share Price is delayed by 15 minutes
Get Live Data
215.00    2.50 (1.18%)
Bid:
210.00
Ask:
220.00
Spread: 10.00 (4.762%)
Market Cap: £173.69m
W7L Live PriceLast checked at - London Stock Exchange

Intraday Warpaint London Share Chart

AGM Statement

26 Jun 2017 07:00

RNS Number : 0781J
Warpaint London PLC
26 June 2017
Β 

26 June 2017

Warpaint London plc

("Warpaint London" or the "Company" or the "Group")

AGM Statement

Β 

At the Annual General Meeting of Warpaint London plc (AIM: W7L) to be held later today, Clive Garston, Chairman of the Company, will make the following statement:

"I am pleased to report that the Company continues to trade in line with expectations. So far in 2017, we have seen encouraging growth across all our sales territories worldwide, apart from Europe where sales remain similar to the corresponding period in 2016. I am particularly pleased that our sales strategy for the US, which is the world's largest colour cosmetics market, has delivered double-digit sales growth compared to the same period last year.

We recently launched our new Very Vegan range of products and early sales, whilst modest in the context of the Group, have been encouraging. We will continue to innovate and look for further opportunities to introduce new products into our mix.

Our E-commerce strategy remains on track and is a growing contributor to the Group. Supported by celebrity endorsements, particularly through social media, we expect the importance of on-line sales to continue to grow.

I am pleased with the performance of the Group since admission to AIM in November last year. Being quoted on AIM has been a positive experience for the Company, in particular helping the recognition and development of the W7 brand globally.

We look forward to updating the market at the time of the release of our interim results in September 2017."

Β 

Enquiries:

Warpaint London plc

Sam Bazini - Joint Chief Executive

Eoin Macleod - Joint Chief Executive

Neil Rodol - Chief Financial Officer

Β 

020 3053 8671

Β 

Stockdale Securities Limited (Nominated Adviser and Broker)

Andy Crossley, Antonio Bossi, Ed Thomas - Corporate Finance

Fiona Conroy - Corporate Broking

Β 

020 7601 6100

Β 

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Heather Armstrong

Miles Nolan

020 3053 8671

Β 

Β 

About Warpaint London plc

Warpaint London is a colour cosmetics business, based in Iver, Buckinghamshire. It is made up of two divisions: close-out and own-brand. The second and larger own-brand division consists primarily of the Group's flagship brand, W7 - an extremely creative, design-focused cosmetic brand proposition with a focus on the 16-30 age range, delivering high-quality cosmetics at affordable prices. W7 brand has grown organically since its inception in 2002 and now contains over 500 items which are sold into high street retailers and independent beauty shops across the UK, Europe, Australia and the US. In 2016, W7 was supplied to over 250 customers in more than 50 countries.

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMOKPDBFBKKDAB
Date   Source Headline
6th Jan 202510:33 amPRNForm 8.3 - Warpaint London Plc
3rd Jan 20251:57 pmRNSForm 8.5 (EPT/RI)
3rd Jan 20251:49 pmGNWForm 8.3 - Warpaint London Plc
3rd Jan 202512:37 pmPRNForm 8.3 - Warpaint London Plc Amendment
3rd Jan 202511:57 amRNSForm 8.3 - [Warpaint London plc]
3rd Jan 202511:46 amPRNForm 8.3 - Warpaint London Plc
3rd Jan 202511:26 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
3rd Jan 202510:15 amRNSForm 8.3 - Warpaint London plc
2nd Jan 20253:20 pmGNWForm 8.3 - Warpaint London Plc
2nd Jan 202511:12 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
2nd Jan 20259:58 amRNSForm 8.5 (EPT/RI)
31st Dec 202411:25 amGNWForm 8.3 - Warpaint London Plc
31st Dec 202410:43 amRNSForm 8.5 (EPT/RI)
31st Dec 202410:06 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
30th Dec 20241:28 pmPRNForm 8.3 - Warpaint London Plc
30th Dec 202411:35 amRNSForm 8.5 (EPT/RI)
30th Dec 202410:40 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
30th Dec 20249:38 amRNSForm 8.3 - Warpaint London plc
27th Dec 20242:17 pmGNWForm 8.3 - Warpaint London Plc
27th Dec 202411:32 amRNSForm 8.5 (EPT/RI)
27th Dec 202411:10 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
27th Dec 20249:54 amRNSForm 8.3 - Warpaint London plc
24th Dec 202411:36 amGNWForm 8.3 - Warpaint London Plc
24th Dec 202411:09 amGNWForm 8.5 (EPT/RI)
24th Dec 20249:51 amRNSForm 8.5 (EPT/RI)
24th Dec 20249:17 amPRNForm 8.3 - Warpaint London Plc
23rd Dec 202412:26 pmGNWForm 8.3 - Warpaint London Plc
23rd Dec 202411:29 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
23rd Dec 202411:27 amRNSForm 8.3 -WARPAINT LONDON PLC
23rd Dec 202410:45 amRNSForm 8.5 (EPT/RI)
23rd Dec 20249:53 amRNSForm 8.3 - Warpaint London plc
23rd Dec 20249:02 amPRNForm 8.3 - Warpaint London Plc
23rd Dec 20248:00 amRNSForm 8.3 - Warpaint London Plc
20th Dec 202412:46 pmGNWForm 8.3 - Warpaint London Plc
20th Dec 202411:56 amPRNForm 8.3 - Warpaint London Plc
20th Dec 202411:55 amRNSForm 8.5 (EPT/RI)
20th Dec 202410:39 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
20th Dec 20249:59 amRNSForm 8.3 - Warpaint London plc
19th Dec 202411:22 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc
19th Dec 202411:11 amPRNForm 8.3 - Warpaint London Plc
19th Dec 202411:03 amGNWForm 8.3 - Warpaint London Plc
19th Dec 202410:52 amRNSForm 8.5 (EPT/RI)
18th Dec 20243:19 pmRNSForm 8.3 - Warpaint London Plc - amendment
18th Dec 20242:53 pmRNSForm 8.3 - Warpaint London
18th Dec 20242:29 pmRNSForm 8.3 - WARPAINT LONDON PLC
18th Dec 20241:05 pmGNWForm 8.3 - Warpaint London Plc
18th Dec 202411:35 amPRNForm 8.3 - Warpaint London Plc
18th Dec 202410:57 amRNSForm 8.5 (EPT/RI)
18th Dec 202410:56 amRNSForm 8.3 - WARPAINT LONDON PLC
18th Dec 202410:47 amGNWForm 8.5 (EPT/RI) - Warpaint London Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.